Link-Gelles, R., Rowley, E. A. K., Irving, S. A., Klein, N. P., Grannis, S. J., Ong, T. C., Ball, S. W., DeSilva, M. B., Dascomb, K., Naleway, A. L., Koppolu, P., Zerbo, O., Fireman, B., Hansen, J., Timbol, J., Block, L., Dixon, B. E., Duszynski, T. J., Allen, K. S., … Payne, A. B. (2025). Estimated 2023-2024 COVID-19 Vaccine Effectiveness in Adults. JAMA Network Open, 8(6), e2517402. https://doi.org/10.1001/jamanetworkopen.2025.17402

Andrews, L. I. B., Halloran, M. E., Neuzil, K. M., van der Laan, L., Huang, Y., Andriesen, J., Patel, M., Fisher, L. H., Janes, H., Rouphael, N., Walsh, S. R., Theodore, D. A., Tieu, H.-V., Sobieszczyk, M., El Sahly, H. M., Baden, L. R., Falsey, A. R., Campbell, T. B., Kelley, C. F., … Zorrilla, C. D. (2025). Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data. JAMA Network Open, 8(5), e2512763. https://doi.org/10.1001/jamanetworkopen.2025.12763

Rowley, E. A., Mitchell, P. K., Yang, D.-H., Lewis, N., Dixon, B. E., Vazquez-Benitez, G., Fadel, W. F., Essien, I. J., Naleway, A. L., Stenehjem, E., Ong, T. C., Gaglani, M., Natarajan, K., Embi, P., Wiegand, R. E., Link-Gelles, R., Tenforde, M. W., & Fireman, B. (2025). Methods to Adjust for Confounding in Test-Negative Design COVID-19 Effectiveness Studies: Simulation Study. JMIR Formative Research, 9, e58981. https://doi.org/10.2196/58981

Payne, A. B., Watts, J. A., Mitchell, P. K., Dascomb, K., Irving, S. A., Klein, N. P., Grannis, S. J., Ong, T. C., Ball, S. W., DeSilva, M. B., Natarajan, K., Sheffield, T., Bride, D., Arndorfer, J., Naleway, A. L., Koppolu, P., Fireman, B., Zerbo, O., Timbol, J., … Link-Gelles, R. (2024). Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis. The Lancet, 404(10462), 1547–1559. https://doi.org/10.1016/s0140-6736(24)01738-0

Moore, M., Zhu, Y., Hirsch, I., White, T., Reiner, R. C., Barber, R. M., Pigott, D., Collins, J. K., Santoni, S., Sobieszczyk, M. E., & Janes, H. (2024). Estimating vaccine efficacy during open-label follow-up of COVID-19 vaccine trials based on population-level surveillance data. Epidemics, 47, 100768. https://doi.org/10.1016/j.epidem.2024.100768

Tenforde, M. W., Weber, Z. A., Yang, D.-H., DeSilva, M. B., Dascomb, K., Irving, S. A., Naleway, A. L., Gaglani, M., Fireman, B., Lewis, N., Zerbo, O., Goddard, K., Timbol, J., Hansen, J. R., Grisel, N., Arndorfer, J., McEvoy, C. E., Essien, I. J., Rao, S., … Klein, N. P. (2023). Influenza Vaccine Effectiveness Against Influenza A–Associated Emergency Department, Urgent Care, and Hospitalization Encounters Among US Adults, 2022–2023. The Journal of Infectious Diseases, 230(1), 141–151. https://doi.org/10.1093/infdis/jiad542

Falsey, A. R., Sobieszczyk, M. E., Hirsch, I., Sproule, S., Robb, M. L., Corey, L., Neuzil, K. M., Hahn, W., Hunt, J., Mulligan, M. J., McEvoy, C., DeJesus, E., Hassman, M., Little, S. J., Pahud, B. A., Durbin, A., Pickrell, P., Daar, E. S., Bush, L., … Gonzalez-Lopez, A. (2021). Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine. New England Journal of Medicine, 385(25), 2348–2360. https://doi.org/10.1056/nejmoa2105290